Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer - United Kingdom
doi 10.1186/s12885-020-06813-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Updated Study on Action Mechanisms of Cereblon as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2019English

SLC2A2 (GLUT2) as a Novel Prognostic Factor for Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Modularity of the Metabolic Gene Network as a Prognostic Biomarker for Hepatocellular Carcinoma

Oncotarget
Oncology
2018English

Identification and Validation of Alternative Splicing Isoforms as Novel Biomarker Candidates in Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2018English

Plasma Osteopontin as a Novel Diagnostic Biomarker for Early Detection of Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

Circular RNA Hsa_circ_0078602 May Have Potential as a Prognostic Biomarker for Patients With Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

Identification of AUNIP as a Candidate Diagnostic and Prognostic Biomarker for Oral Squamous Cell Carcinoma

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

SAC3D1: A Novel Prognostic Marker in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2018English

Histamine Is a Helpful Novel Serological Biomarker for Experimental Hepatocellular Carcinoma

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy